
Three-dose Covid-19 vaccine produces strong immune response in children ages 6 months to 5 years, Pfizer and BioNTech say
CNN
Three child-size doses of the Pfizer/BioNTech Covid-19 vaccine appeared to be safe and showed a strong immune response in children ages 6 months to 5 years, the companies said Monday. The vaccine makers said they will finish submitting the trial data to the US Food and Drug Administration this week.
More Related News

As lawmakers demand answers over reports that the US military carried out a follow-up strike that killed survivors during an attacked on an alleged drug boat in the Caribbean, a career Navy SEAL who has spent most of his 30 years of military experience in special operations will be responsible for providing them.












